{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:26:54Z","timestamp":1767864414862,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,3,28]],"date-time":"2009-03-28T00:00:00Z","timestamp":1238198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00404-009-1051-y","type":"journal-article","created":{"date-parts":[[2009,3,27]],"date-time":"2009-03-27T05:30:29Z","timestamp":1238131829000},"page":"35-42","source":"Crossref","is-referenced-by-count":27,"title":["Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome"],"prefix":"10.1007","volume":"281","author":[{"given":"Levent","family":"Kebapcilar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuneyt Eftal","family":"Taner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse Gul","family":"Kebapcilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Alacacioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail","family":"Sari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,28]]},"reference":[{"key":"1051_CR1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","volume":"333","author":"S Franks","year":"1995","unstructured":"Franks S (1995) Polycystic ovary syndrome. N Engl J Med 333:853\u2013861. doi: 10.1056\/NEJM199509283331307","journal-title":"N Engl J Med"},{"key":"1051_CR2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/09513599609012817","volume":"10","author":"S Eckardstein von","year":"1996","unstructured":"von Eckardstein S, von Eckardstein A, Bender HG, Schulte H, Assmann G (1996) Elevated low-density lipoprotein-cholesterol in women with polycystic ovary syndrome. Gynecol Endocrinol 10:311\u2013318. doi: 10.3109\/09513599609012817","journal-title":"Gynecol Endocrinol"},{"key":"1051_CR3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2265.1993.tb00996.x","volume":"38","author":"GS Conway","year":"1993","unstructured":"Conway GS, Clark PM, Wong D (1993) Hyperinsulinaemia in the polycystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin. Clin Endocrinol (Oxf) 38:219\u2013222. doi: 10.1111\/j.1365-2265.1993.tb00996.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1051_CR4","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1210\/jc.2004-1487","volume":"90","author":"C Meyer","year":"2005","unstructured":"Meyer C, McGrath BP, Cameron J, Kotsopoulos D, Teede HJ (2005) Vascular dysfunction and metabolic parameters in polycystic ovary syndrome. J Clin Endocrinol Metab 90:4630\u20134635. doi: 10.1210\/jc.2004-1487","journal-title":"J Clin Endocrinol Metab"},{"key":"1051_CR5","doi-asserted-by":"crossref","unstructured":"Kebapcilar L, Taner CE, Kebapcilar AG, Sari I (2008) High mean platelet volume, low-grade systemic coagulation and fibrinolytic activation are associated with androgen and insulin levels in polycystic ovary syndrome. Arch Gynecol Obstet [Epub ahead of print]","DOI":"10.1007\/s00404-008-0884-0"},{"key":"1051_CR6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/147323000603400513","volume":"34","author":"G Derosa","year":"2006","unstructured":"Derosa G, Dangelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo S, Montagna L, Gravina A, Ferrari I, Galli S, Paniga S, Cicero AF (2006) Effects of rosiglitazone and pioglitazone combined with metformin on the prothrombotic state of patients with type 2 diabetes mellitus and metabolic syndrome. J Int Med Res 34:545\u2013555","journal-title":"J Int Med Res"},{"key":"1051_CR7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome PCOS. Hum Reprod 19:41\u201347. doi: 10.1093\/humrep\/deh098","journal-title":"Hum Reprod"},{"key":"1051_CR8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2002-020997","volume":"88","author":"L Morin-Papunen","year":"2003","unstructured":"Morin-Papunen L, Vauhkonen I, Koivunen R, Ruokonen A, Martikainen H, Tapanainen JS (2003) Metformin versus ethinyl estradiol\u2013cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study. J Clin Endocrinol Metab 88:148\u2013156. doi: 10.1210\/jc.2002-020997","journal-title":"J Clin Endocrinol Metab"},{"key":"1051_CR9","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.2007-0282","volume":"92","author":"M Luque-Ram\u00edrez","year":"2007","unstructured":"Luque-Ram\u00edrez M, Alvarez-Blasco F, Botella-Carretero JI, Mart\u00ednez-Bermejo E, Lasunci\u00f3n MA, Escobar-Morreale HF (2007) Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome. J Clin Endocrinol Metab 92:2453\u20132461. doi: 10.1210\/jc.2007-0282","journal-title":"J Clin Endocrinol Metab"},{"key":"1051_CR10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/09513590802291824","volume":"24","author":"F Karakurt","year":"2008","unstructured":"Karakurt F, Gumus II, Bavbek N, Kargili A, Koca C, Selcoki Y, Ozbek M, Kosar A, Akcay A (2008) Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome. Gynecol Endocrinol 24:491\u2013497. doi: 10.1080\/09513590802291824","journal-title":"Gynecol Endocrinol"},{"key":"1051_CR11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1530\/EJE-08-0725","volume":"160","author":"M Luque-Ram\u00edrez","year":"2009","unstructured":"Luque-Ram\u00edrez M, Mendieta-Azcona C, del Rey S\u00e1nchez JM, Mat\u00edes M, Escobar-Morreale HF (2009) Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking. Eur J Endocrinol 160:469\u2013480. doi: 10.1530\/EJE-08-0725","journal-title":"Eur J Endocrinol"},{"key":"1051_CR12","first-page":"CR387","volume":"11","author":"N Kili\u00e7li-Camur","year":"2005","unstructured":"Kili\u00e7li-Camur N, Demirtun\u00e7 R, Konuralp C, Eskiser A, Ba\u015faran Y (2005) Could mean platelet volume be a predictive marker for acute myocardial infarction? Med Sci Monit 11:CR387\u2013CR392","journal-title":"Med Sci Monit"},{"key":"1051_CR13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.1983.tb02052.x","volume":"53","author":"JA Jakubowski","year":"1983","unstructured":"Jakubowski JA, Thompson CB, Vaillancourt R et al (1983) Arachidonic acid metabolism by platelets of differing size. Br J Haematol 53:503\u2013511. doi: 10.1111\/j.1365-2141.1983.tb02052.x","journal-title":"Br J Haematol"},{"key":"1051_CR14","first-page":"139","volume":"85","author":"P Moghetti","year":"2000","unstructured":"Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, Zanolin E, Muggeo M (2000) Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 85:139\u2013146. doi: 10.1210\/jc.85.1.139","journal-title":"J Clin Endocrinol Metab"},{"key":"1051_CR15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jcem.87.2.8261","volume":"87","author":"R Fleming","year":"2002","unstructured":"Fleming R, Hopkinson ZE, Wallace AM, Greer IA, Sattar N (2002) Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metab 87:569\u2013574. doi: 10.1210\/jc.87.2.569","journal-title":"J Clin Endocrinol Metab"},{"key":"1051_CR16","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/humrep\/17.7.1729","volume":"17","author":"K Elter","year":"2002","unstructured":"Elter K, Imir G, Durmusoglu F (2002) Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol\u2013cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study. Hum Reprod 17:1729\u20131737. doi: 10.1093\/humrep\/17.7.1729","journal-title":"Hum Reprod"},{"key":"1051_CR17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejogrb.2004.06.035","volume":"118","author":"M Mitkov","year":"2005","unstructured":"Mitkov M, Pehlivanov B, Terzieva D (2005) Combined use of metformin and ethinyl estradiol\u2013cyproterone acetate in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 118:209\u2013213. doi: 10.1016\/j.ejogrb.2004.06.035","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1051_CR18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/09513590802217027","volume":"24","author":"J Wu","year":"2008","unstructured":"Wu J, Zhu Y, Jiang Y, Cao Y (2008) Effects of metformin and ethinyl estradiol\u2013cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome. Gynecol Endocrinol 24:392\u2013398. doi: 10.1080\/09513590802217027","journal-title":"Gynecol Endocrinol"},{"key":"1051_CR19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2265.1999.00701.x","volume":"50","author":"R Pasquali","year":"1999","unstructured":"Pasquali R, Gambineri A, Anconetani B, Vicennati V, Colitta D, Caramelli E, Casimirri F, Morselli-Labate AM (1999) The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen\u2013progestogen treatment. Clin Endocrinol (Oxf) 50:517\u2013527. doi: 10.1046\/j.1365-2265.1999.00701.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1051_CR20","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1210\/jc.2003-030328","volume":"88","author":"A Cagnacci","year":"2003","unstructured":"Cagnacci A, Paoletti AM, Renzi A, Orr\u00f9 M, Pilloni M, Melis GB, Volpe A (2003) Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel. J Clin Endocrinol Metab 88:3621\u20133625. doi: 10.1210\/jc.2003-030328","journal-title":"J Clin Endocrinol Metab"},{"key":"1051_CR21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/humrep\/deh588","volume":"20","author":"D Cibula","year":"2005","unstructured":"Cibula D, Fanta M, Vrbikova J, Stanicka S, Dvorakova K, Hill M, Skrha J, Zivny J, Skrenkova J (2005) The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients. Hum Reprod 20:180\u2013184. doi: 10.1093\/humrep\/deh588","journal-title":"Hum Reprod"},{"key":"1051_CR22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/eje.0.1500215","volume":"150","author":"J Vrb\u00edkov\u00e1","year":"2004","unstructured":"Vrb\u00edkov\u00e1 J, Stanick\u00e1 S, Dvor\u00e1kov\u00e1 K, Hill M, Vondra K, Bendlov\u00e1 B, St\u00e1rka L (2004) Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome. Eur J Endocrinol 150:215\u2013223. doi: 10.1530\/eje.0.1500215","journal-title":"Eur J Endocrinol"},{"key":"1051_CR23","first-page":"E851","volume":"262","author":"A Holmang","year":"1992","unstructured":"Holmang A, Larsson BM, Brzezinska Z, Bjorntorp P (1992) Effects of short-term testosterone exposure on insulin sensitivity of muscles in female rats. Am J Physiol 262:E851\u2013E855","journal-title":"Am J Physiol"},{"key":"1051_CR24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2337\/diab.45.5.615","volume":"45","author":"J Rincon","year":"1996","unstructured":"Rincon J, Holmang A, Wahlstrom EO, Lonnroth P, Bjorntorp P, Zierath JR, Wallberg-Henriksson H (1996) Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes 45:615\u2013621. doi: 10.2337\/diabetes.45.5.615","journal-title":"Diabetes"},{"key":"1051_CR25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bpobgyn.2004.05.003","volume":"18","author":"L Moran","year":"2004","unstructured":"Moran L, Norman RJ (2004) Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:719\u2013736. doi: 10.1016\/j.bpobgyn.2004.05.003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1051_CR26","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/jc.2002-020815","volume":"88","author":"LJ Moran","year":"2003","unstructured":"Moran LJ, Noakes M, Clifton PM, Tomlinson L, Norman RJ (2003) Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:812\u2013819. doi: 10.1210\/jc.2002-020815","journal-title":"J Clin Endocrinol Metab"},{"key":"1051_CR27","first-page":"293","volume":"20","author":"KM Hoeger","year":"2006","unstructured":"Hoeger KM (2006) Role of lifestyle modification in the management of polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 20:293\u2013310","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1051_CR28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejogrb.2005.11.019","volume":"126","author":"M Mitkov","year":"2006","unstructured":"Mitkov M, Pehlivanov B, Terzieva D (2006) Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 126:93\u201398. doi: 10.1016\/j.ejogrb.2005.11.019","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-009-1051-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-009-1051-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-009-1051-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:53:50Z","timestamp":1559051630000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-009-1051-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,28]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["1051"],"URL":"https:\/\/doi.org\/10.1007\/s00404-009-1051-y","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,28]]}}}